1,2-dimethylhydrazine multiple interactions ISO Macroh2a1 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of MACROH2A1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO Macroh2a1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of MACROH2A1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO Macroh2a1 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of MACROH2A1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO Macroh2a1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of MACROH2A1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO Macroh2a1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MACROH2A1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Macroh2a1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of MACROH2A1 mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to MACROH2A1 promoter] CTD PMID:17942748 and PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MACROH2A1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Macroh2a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MACROH2A1 mRNA CTD PMID:21570461 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of MACROH2A1 mRNA CTD PMID:21346803 2-amino-14,16-dimethyloctadecan-3-ol decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 2-amino-14 and 16-dimethyloctadecan-3-ol results in decreased expression of MACROH2A1 protein CTD PMID:32044396 2-hydroxypropanoic acid increases expression ISO MACROH2A1 (Homo sapiens) 6480464 Lactic Acid results in increased expression of MACROH2A1 mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine decreases expression ISO Macroh2a1 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of MACROH2A1 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MACROH2A1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MACROH2A1 mRNA CTD PMID:28628672 3H-1,2-dithiole-3-thione increases expression EXP 6480464 1 and 2-dithiol-3-thione results in increased expression of MACROH2A1 mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane decreases expression ISO Macroh2a1 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in decreased expression of MACROH2A1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MACROH2A1 mRNA CTD PMID:28628672 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of MACROH2A1 mRNA CTD PMID:21346803 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of MACROH2A1 mRNA CTD PMID:30047161 aflatoxin B1 increases expression ISO MACROH2A1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of MACROH2A1 mRNA CTD PMID:22100608 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of MACROH2A1 mRNA CTD PMID:18355885 amitriptyline affects expression EXP 6480464 Amitriptyline affects the expression of MACROH2A1 mRNA CTD PMID:18355885 amitrole increases expression EXP 6480464 Amitrole results in increased expression of MACROH2A1 mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MACROH2A1 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of MACROH2A1 mRNA CTD PMID:24449571 arsane affects methylation ISO MACROH2A1 (Homo sapiens) 6480464 Arsenic affects the methylation of MACROH2A1 gene CTD PMID:25304211 arsane increases ubiquitination ISO MACROH2A1 (Homo sapiens) 6480464 Arsenic results in increased ubiquitination of MACROH2A1 protein CTD PMID:35994080 arsenic atom affects methylation ISO MACROH2A1 (Homo sapiens) 6480464 Arsenic affects the methylation of MACROH2A1 gene CTD PMID:25304211 arsenic atom increases ubiquitination ISO MACROH2A1 (Homo sapiens) 6480464 Arsenic results in increased ubiquitination of MACROH2A1 protein CTD PMID:35994080 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of MACROH2A1 gene CTD PMID:35440735 belinostat multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MACROH2A1 mRNA CTD PMID:27188386 belinostat decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 belinostat results in decreased expression of MACROH2A1 mRNA CTD PMID:26272509 benzo[a]pyrene decreases methylation ISO MACROH2A1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of MACROH2A1 5' UTR CTD PMID:27901495 benzo[a]pyrene affects methylation ISO MACROH2A1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of MACROH2A1 promoter CTD PMID:27901495 bisphenol A increases expression ISO Macroh2a1 (Mus musculus) 6480464 bisphenol A results in increased expression of MACROH2A1 mRNA CTD PMID:26063408 bisphenol A increases expression ISO MACROH2A1 (Homo sapiens) 6480464 bisphenol A results in increased expression of MACROH2A1 protein CTD PMID:37567409 bisphenol A decreases methylation ISO MACROH2A1 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of MACROH2A1 gene CTD PMID:31601247 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MACROH2A1 mRNA CTD PMID:25181051 more ... bisphenol A multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MACROH2A1 mRNA CTD PMID:28628672 Bisphenol B increases expression ISO MACROH2A1 (Homo sapiens) 6480464 bisphenol B results in increased expression of MACROH2A1 protein CTD PMID:34186270 bisphenol F increases expression ISO MACROH2A1 (Homo sapiens) 6480464 bisphenol F results in increased expression of MACROH2A1 protein CTD PMID:34186270 bleomycin A2 decreases expression EXP 6480464 Bleomycin results in decreased expression of MACROH2A1 protein CTD PMID:25933445 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of MACROH2A1 promoter CTD PMID:22457795 caffeine affects phosphorylation ISO MACROH2A1 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of MACROH2A1 protein CTD PMID:35688186 carbon nanotube increases expression ISO Macroh2a1 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of MACROH2A1 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to MACROH2A1 gene] CTD PMID:28238834 chlormequat chloride increases expression EXP 6480464 Chlormequat results in increased expression of MACROH2A1 protein CTD PMID:34958886 chlorpyrifos decreases expression ISO Macroh2a1 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of MACROH2A1 mRNA CTD PMID:37019170 choline multiple interactions ISO Macroh2a1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MACROH2A1 gene CTD PMID:20938992 cisplatin increases expression ISO MACROH2A1 (Homo sapiens) 6480464 Cisplatin results in increased expression of MACROH2A1 mRNA CTD PMID:27594783 clofibrate increases expression ISO Macroh2a1 (Mus musculus) 6480464 Clofibrate results in increased expression of MACROH2A1 mRNA CTD PMID:17585979 clomipramine affects expression EXP 6480464 Clomipramine affects the expression of MACROH2A1 mRNA CTD PMID:18355885 dexamethasone multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MACROH2A1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MACROH2A1 mRNA CTD PMID:28628672 disodium selenite increases expression ISO MACROH2A1 (Homo sapiens) 6480464 Sodium Selenite results in increased expression of MACROH2A1 mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects response to substance ISO MACROH2A1 (Homo sapiens) 6480464 MACROH2A1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 doxorubicin increases expression ISO MACROH2A1 (Homo sapiens) 6480464 Doxorubicin results in increased expression of MACROH2A1 mRNA CTD PMID:29803840 doxorubicin affects expression ISO MACROH2A1 (Homo sapiens) 6480464 Doxorubicin affects the expression of MACROH2A1 protein CTD PMID:29385562 doxorubicin decreases expression ISO Macroh2a1 (Mus musculus) 6480464 Doxorubicin results in decreased expression of MACROH2A1 mRNA CTD PMID:19277126 entinostat decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 entinostat results in decreased expression of MACROH2A1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MACROH2A1 mRNA CTD PMID:27188386 fenthion increases expression ISO Macroh2a1 (Mus musculus) 6480464 Fenthion results in increased expression of MACROH2A1 mRNA CTD PMID:34813904 finasteride increases expression EXP 6480464 Finasteride results in increased expression of MACROH2A1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO Macroh2a1 (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 formaldehyde decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of MACROH2A1 mRNA CTD PMID:23649840 FR900359 affects phosphorylation ISO MACROH2A1 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of MACROH2A1 protein CTD PMID:37730182 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MACROH2A1 mRNA CTD PMID:22061828 hydroquinone decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 hydroquinone results in decreased expression of MACROH2A1 protein CTD PMID:35698848 imipramine affects expression EXP 6480464 Imipramine affects the expression of MACROH2A1 mRNA CTD PMID:18355885 indometacin multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of MACROH2A1 mRNA and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of MACROH2A1 mRNA CTD PMID:28628672 ivermectin decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of MACROH2A1 protein CTD PMID:32959892 ketoconazole affects expression EXP 6480464 Ketoconazole affects the expression of MACROH2A1 mRNA CTD PMID:18355885 L-methionine multiple interactions ISO Macroh2a1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MACROH2A1 gene CTD PMID:20938992 lead(0) affects expression ISO MACROH2A1 (Homo sapiens) 6480464 Lead affects the expression of MACROH2A1 mRNA CTD PMID:28903495 mercury dibromide decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 mercuric bromide results in decreased expression of MACROH2A1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MACROH2A1 mRNA CTD PMID:27188386 methidathion increases expression ISO Macroh2a1 (Mus musculus) 6480464 methidathion results in increased expression of MACROH2A1 mRNA CTD PMID:34813904 methimazole increases expression EXP 6480464 Methimazole results in increased expression of MACROH2A1 mRNA CTD PMID:30047161 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of MACROH2A1 gene CTD PMID:35440735 methyl methanesulfonate decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of MACROH2A1 mRNA CTD PMID:23649840 N-methyl-4-phenylpyridinium increases expression ISO Macroh2a1 (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MACROH2A1 protein CTD PMID:26558463 p-chloromercuribenzoic acid decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in decreased expression of MACROH2A1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MACROH2A1 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MACROH2A1 mRNA CTD PMID:27188386 panobinostat decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 Panobinostat results in decreased expression of MACROH2A1 mRNA CTD PMID:26272509 paracetamol increases expression ISO MACROH2A1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of MACROH2A1 mRNA CTD PMID:22230336 perfluorohexanesulfonic acid decreases expression ISO Macroh2a1 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in decreased expression of MACROH2A1 mRNA CTD PMID:37995155 pirinixic acid decreases expression ISO Macroh2a1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of MACROH2A1 mRNA CTD PMID:17426115 propiconazole decreases expression ISO Macroh2a1 (Mus musculus) 6480464 propiconazole results in decreased expression of MACROH2A1 mRNA CTD PMID:21278054 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of MACROH2A1 mRNA CTD PMID:30047161 rac-lactic acid increases expression ISO MACROH2A1 (Homo sapiens) 6480464 Lactic Acid results in increased expression of MACROH2A1 mRNA CTD PMID:30851411 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of MACROH2A1 mRNA CTD PMID:16079270 rotenone increases expression EXP 6480464 Rotenone results in increased expression of MACROH2A1 protein CTD PMID:35544339 SB 431542 multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 sodium arsenite affects expression ISO MACROH2A1 (Homo sapiens) 6480464 sodium arsenite affects the expression of MACROH2A1 mRNA CTD PMID:29319823 sodium arsenite increases expression ISO MACROH2A1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of MACROH2A1 mRNA CTD PMID:34032870 sodium arsenite decreases expression ISO Macroh2a1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of MACROH2A1 protein CTD PMID:29044176 sodium fluoride decreases expression ISO Macroh2a1 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of MACROH2A1 protein CTD PMID:28918527 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of MACROH2A1 mRNA CTD PMID:30047161 sulindac decreases expression EXP 6480464 Sulindac results in decreased expression of MACROH2A1 mRNA CTD PMID:24136188 tamoxifen affects expression ISO Macroh2a1 (Mus musculus) 6480464 Tamoxifen affects the expression of MACROH2A1 mRNA CTD PMID:17555576 tert-butyl hydroperoxide decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of MACROH2A1 mRNA CTD PMID:15336504 titanium dioxide increases expression ISO Macroh2a1 (Mus musculus) 6480464 titanium dioxide results in increased expression of MACROH2A1 mRNA CTD PMID:29264374 trichostatin A decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 trichostatin A results in decreased expression of MACROH2A1 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MACROH2A1 mRNA CTD PMID:27188386 triptonide increases expression ISO Macroh2a1 (Mus musculus) 6480464 triptonide results in increased expression of MACROH2A1 mRNA CTD PMID:33045310 troglitazone decreases expression ISO Macroh2a1 (Mus musculus) 6480464 Troglitazone results in decreased expression of MACROH2A1 mRNA CTD PMID:28973697 valproic acid affects expression ISO MACROH2A1 (Homo sapiens) 6480464 Valproic Acid affects the expression of MACROH2A1 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO MACROH2A1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MACROH2A1 mRNA CTD PMID:27188386 valproic acid decreases methylation ISO MACROH2A1 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of MACROH2A1 gene CTD PMID:29154799 valproic acid decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of MACROH2A1 mRNA CTD PMID:19101580 more ... vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MACROH2A1 mRNA CTD PMID:19015723 vorinostat decreases expression ISO MACROH2A1 (Homo sapiens) 6480464 Vorinostat results in decreased expression of MACROH2A1 mRNA CTD PMID:27188386